## Gene Summary
NFATC1 (Nuclear Factor Of Activated T-Cells 1) is a member of the NFAT family, which is a group of transcription factors known to play crucial roles in immune response. This gene encodes a protein that is involved in the regulation of gene expression following the activation of T-cells, among other functions. NFATC1 is activated and translocated into the nucleus in response to signals that increase intracellular calcium levels and stimulate calcineurin activity. The gene is expressed in various cells of the immune system but is most prominently seen in T lymphocytes. It is also involved in other biological processes including development and adaptation.

## Gene Drugs, Diseases, Phenotypes, and Pathways
NFATC1 has been implicated in several disease states primarily related to immune and inflammatory responses. Conditions such as autoimmune diseases, cardiac hypertrophy, and some forms of cancer have been associated with dysregulation of NFATC1 activity. The gene's role in immune response also ties it to phenotypes related to inflammation and cellular proliferation. Pathways involving NFATC1 include Calcineurin-NFAT signaling, which is significant in T-cell activation and cytokine production, contributing notably to immune system regulation and interaction with various cytokines and growth factors.

## Pharmacogenetics
In the context of pharmacogenetics, NFATC1's role is significant in the modulation of immune response through drugs that affect the calcineurin-NFAT pathway. Drugs such as Cyclosporine and Tacrolimus, which are immunosuppressants, inhibit the phosphatase activity of calcineurin leading to reduced NFATC1 dephosphorylation and nuclear translocation, thereby suppressing the production of interleukins like IL-2 in T-cells. This mechanism is crucial for preventing organ rejection in transplant patients and in the treatment of autoimmune diseases. The individual differences in the NFATC1 gene can affect the efficacy and safety of such treatments, making its study valuable in personalized medicine.